A detailed history of Nebula Research & Development LLC transactions in Stryker Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 2,436 shares of SYK stock, worth $899,907. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,436
Holding current value
$899,907
% of portfolio
0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$315.94 - $371.96 $769,629 - $906,094
2,436 New
2,436 $880 Million
Q1 2024

May 15, 2024

SELL
$293.94 - $358.71 $309,224 - $377,362
-1,052 Reduced 47.77%
1,150 $412 Million
Q4 2023

Feb 14, 2024

BUY
$253.85 - $299.46 $558,977 - $659,410
2,202 New
2,202 $659 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.